Activators of NUDCD2 function through a variety of biochemical mechanisms to enhance its activity within cellular processes. Molecules that elevate intracellular cAMP levels, such as adenylyl cyclase stimulators and phosphodiesterase inhibitors, create an environment that promotes the phosphorylation of proteins within the pathways NUDCD2 is a part of, thereby increasing its functional activity. Analogously, membrane-permeable analogs of cAMP serve a similar function, activating cAMP-dependent protein kinases which can directly phosphorylate NUDCD2 or its regulatory proteins. On a different note, the activation of AMPK by compounds that mimic energy stress leads to a cascade of events that potentially culminate in the activation of NUDCD2 through phosphorylation or other post-translational modifications.
Further to these mechanisms, certain activators function by modulating the activity of enzymes that post-translationally modify proteins involved in NUDCD2's pathways. For instance, enhancers of protein kinase C can lead to a phosphorylation cascade, indirectly resulting in NUDCD2 activation. Conversely, specific kinase inhibitors might induce compensatory responses that activate NUDCD2 as part of a feedback mechanism. Moreover, small molecules that stimulate autophagy or modulate gene expression through nuclear receptor binding can influence cellular pathways that intersect with NUDCD2 activity. For example, agents that inhibit specific kinases implicated in the Wnt signaling pathway can indirectly lead to the activation of NUDCD2, as this signaling is known to intersect with pathways that NUDCD2 may influence.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective phosphodiesterase inhibitor that prevents cAMP degradation, thereby sustaining an environment conducive to NUDCD2 activation through cAMP-dependent pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Membrane-permeable cAMP analog that activates cAMP-dependent protein kinases, potentially leading to the phosphorylation and activation of NUDCD2. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A polyphenol that may activate AMPK, which in turn could trigger downstream signaling cascades that lead to the activation of NUDCD2. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK which can influence various signaling pathways, possibly including those that enhance the activity of NUDCD2. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Activates AMPK which can modulate signaling pathways linked to NUDCD2 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate proteins within signaling pathways involving NUDCD2, leading to its activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Stimulates SIRT1 activation which can deacetylate proteins in pathways that could upregulate NUDCD2 activity. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Induces autophagy through inhibition of acetyltransferase, which may have a role in pathways that converge on the activation of NUDCD2. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Specific inhibitor of PKC that, through negative feedback, could lead to compensatory mechanisms that indirectly activate NUDCD2. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β indirectly leading to activation of Wnt signaling, which may augment pathways influencing NUDCD2 activity. | ||||||